Allergies News and Research

Latest Allergies News and Research

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today that NextGen® Emergency Department Solution version 6.0 is compliant with the ONC 2014 Edition criteria and was certified as an electronic health record (EHR) Module on March 7, 2014 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ACB, in accordance with the applicable Hospital certification criteria adopted by the Secretary of Health and Human Services.

10 Apr 2014

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the publication of data showing that GKT137831, a first in class NOX1 and 4 inhibitor, was able to reverse lung fibrosis associated with aging in a new model of idiopathic pulmonary fibrosis.

10 Apr 2014

NIH study could offer clues for developing new antiviral treatments

A National Institutes of Health study reports that a rare genetic disease, while depleting patients of infection-fighting antibodies, may actually protect them from certain severe or recurrent viral infections.

10 Apr 2014

Food experts to discuss pros and cons of GM crops at Food Integrity and Traceability Conference

One of the world's most contentious food issues - Genetically Modified (GM) crops - will be debated by some of the world's leading authorities on the subject at Queen's University Belfast today (Wednesday day 9 April).

9 Apr 2014

Scientists seek broad, versatile countermeasures effective against several kinds of viruses, other pathogens

A group of University of Washington scientists is seeking broad, versatile countermeasures effective against several different kinds of viruses and other pathogens. The investigators are part of a national push for faster responses to unexpected infectious agents.

9 Apr 2014

Access provides update on new formulation of anti-inflammatory drug amlexanox

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called LexaGard™, for the treatment of inflammatory and ulcerative conditions of the esophagus.

8 Apr 2014

Food allergies are closely linked to spring allergies, says allergist

The Midwest's high tree pollen count is primarily birch and oak, bad news for carrot, celery and almond lovers. "It's healthy if certain foods make your mouth water but it is unhealthy if foods make your nose run or your gums and throat itch," says Joseph Leija, MD, allergist who performs the Gottlieb Allergy Count, the official allergy count for the Midwest.

8 Apr 2014

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

Historically, health insurance covered mental health care differently than other medical care. Recent laws have begun bringing them into balance. ... Congress passed the Mental Health Parity and Addiction Equity Act (MHPAEA) in 2008. ... the MHPAEA applied to large group health plans, both fully and self-insured, and included a cost exemption.

7 Apr 2014

New insights provide novel therapeutic approach against cancer

A major discovery that brings a new drug target to the increasingly exciting landscape of cancer immunotherapy was published yesterday by researchers from La Jolla Institute for Allergy and Immunology and their collaborators from other institutes.

7 Apr 2014

New "3D" method could reduce the need for animal testing

To determine whether new medicines are safe and effective for humans, researchers must first test them in animals, which is costly and time-consuming, as well as ethically challenging.

3 Apr 2014

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

Sanaria received the 2014 Vaccine Industry Excellence Award for the "Best Prophylactic Vaccine" at a ceremony held March 25 in Washington DC during the 14th World Vaccine Congress.

3 Apr 2014

Study finds that stress can make allergies worse

Stress doesn't cause allergies, but easing your mind might mean less allergy flare-ups this spring. According to a study published in the April issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, allergy sufferers with persistent stress experience more allergy flares.

2 Apr 2014

FDA approves ORALAIR sublingual allergy immunotherapy tablet

GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.

2 Apr 2014

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Today Biogen Idec announced that the U.S. Food and Drug Administration has approved ALPROLIX [Coagulation Factor IX (Recombinant), Fc Fusion Protein], the first recombinant, DNA derived hemophilia B therapy with prolonged circulation in the body.

29 Mar 2014

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

Strict guidelines for treating paracetamol overdoses - introduced 18 months ago - are costing the NHS millions of pounds a year, researchers claim.

27 Mar 2014

Study: Guinea pigs and mice can be replaced with non-animal skin sensitization method

Guinea pigs and mice can be replaced with a non-animal skin sensitization method that uses a human-derived skin model, according to a study presented today by the PETA International Science Consortium, Ltd., at the Society of Toxicology's annual meeting.

27 Mar 2014

Redesigned medication alerts in EMR reduce prescribing errors, increase efficiency

Changing how medication alerts are presented in electronic medical records resulted in safer prescribing, increased efficiency and reduced workload for health care providers who placed drug orders in a study published online in the Journal of the American Medical Informatics Association.

27 Mar 2014

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

With the advent of spring comes wind and allergy season, which can prove to be challenging for individuals who rely on contact lenses for clearer vision. According to the Asthma and Allergy Foundation of America, approximately 1 out of 5 individuals in the United States suffer from eye allergies, while nearly half of all individuals who wear contact lenses report irritation and discomfort from wearing contacts during allergy season.

25 Mar 2014

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

Leading Italian developer of innovative eye care solutions S.I.F.I. S.p.A. and Russian pharmaceutical company NovaMedica have entered into an exclusive commercial agreement for NovaMedica to market eight products developed and licensed by SIFI for the treatment of a wide range of ophthalmic pathologies in Russia and the CIS.

25 Mar 2014

IDRI awarded grant extension of $3.4M for identifying new leads and drug targets for tuberculosis

IDRI's drug discovery efforts continue to grow with a recently awarded grant extension of $3.4 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya Parish, Ph.D., IDRI's Vice President of Drug Discovery, and supplements an earlier grant awarded in 2010, for a total of $7.8 million.

25 Mar 2014

Allergies News and Research

Latest Allergies News and Research

NextGen earns ONC 2014 Edition criteria certification for Emergency Department Solution

Genkyotex’s GKT137831 reverses lung fibrosis in new model of idiopathic pulmonary fibrosis

NIH study could offer clues for developing new antiviral treatments

Food experts to discuss pros and cons of GM crops at Food Integrity and Traceability Conference

Scientists seek broad, versatile countermeasures effective against several kinds of viruses, other pathogens

Access provides update on new formulation of anti-inflammatory drug amlexanox

Food allergies are closely linked to spring allergies, says allergist

Research roundup: Mental health parity; nurses' workload; can restaurants reduce portion size?

New insights provide novel therapeutic approach against cancer

New "3D" method could reduce the need for animal testing

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

Study finds that stress can make allergies worse

FDA approves ORALAIR sublingual allergy immunotherapy tablet

Biogen Idec's ALPROLIX receives FDA approval for hemophilia B treatment

Guidelines for treating paracetamol overdoses cost millions of pounds per year, say researchers

Study: Guinea pigs and mice can be replaced with non-animal skin sensitization method

Redesigned medication alerts in EMR reduce prescribing errors, increase efficiency

Tips to avoid eye irritation and longer-term damage to eyes during allergy season

SIFI, NovaMedica agree to market eight products for treatment of ophthalmic pathologies in Russia

IDRI awarded grant extension of $3.4M for identifying new leads and drug targets for tuberculosis

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in